Piper Sandler Reiterates “Neutral” Rating for Tempus AI (NASDAQ:TEM)

Piper Sandler restated their neutral rating on shares of Tempus AI (NASDAQ:TEM) in a report published on Tuesday,Benzinga reports. The firm currently has a $70.00 price target on the stock, up from their previous price target of $40.00.

A number of other brokerages have also issued reports on TEM. Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and boosted their target price for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. JPMorgan Chase & Co. boosted their price objective on Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Stifel Nicolaus cut Tempus AI from a “buy” rating to a “hold” rating and raised their target price for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Needham & Company LLC reiterated a “buy” rating and set a $47.00 price target on shares of Tempus AI in a research note on Wednesday, August 7th. Finally, Loop Capital raised their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Tempus AI has a consensus rating of “Moderate Buy” and an average target price of $54.22.

Tempus AI Trading Down 7.5 %

NASDAQ:TEM opened at $52.40 on Tuesday. The firm has a fifty day moving average price of $51.25. Tempus AI has a 1 year low of $22.89 and a 1 year high of $79.49. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. NEA Management Company LLC acquired a new position in shares of Tempus AI during the second quarter valued at $160,048,000. Novo Holdings A S acquired a new position in Tempus AI during the 2nd quarter valued at about $142,605,000. Revolution Growth Management Company Inc. bought a new position in shares of Tempus AI in the 2nd quarter valued at about $128,133,000. ARK Investment Management LLC grew its position in shares of Tempus AI by 355.0% during the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after buying an additional 1,855,459 shares during the period. Finally, Alphabet Inc. bought a new stake in shares of Tempus AI during the second quarter worth approximately $54,289,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.